BACTERIAL MENINGITIS IN CHILDREN: A REVIEW
Keywords:
Bacterial meningitis; Children; Pediatric infections; Streptococcus pneumoniae; Neisseria meningitidis; Cerebrospinal fluid; Neuroinflammation; Vaccination; Pediatric neurology; Central nervous system infectionsAbstract
Bacterial meningitis remains one of the most severe infectious emergencies in pediatric medicine and continues to contribute substantially to global childhood morbidity and mortality despite major advances in vaccination and antimicrobial therapy. The disease is characterized by acute inflammation of the meninges caused by invasive bacterial pathogens, resulting in rapid neurological deterioration, systemic inflammatory response, and potentially irreversible complications. Neonates and young children are particularly vulnerable because of immature immune defense mechanisms and increased susceptibility to hematogenous dissemination of pathogens into the central nervous system.
References
1.World Health Organization. Defeating meningitis by 2030: global road map. Geneva: WHO; 2024.
2.Centers for Disease Control and Prevention. Bacterial meningitis. Updated 2025.
3.van de Beek D, Brouwer MC, Hasbun R, Koedel U, Whitney CG, Wijdicks EFM. Community-acquired bacterial meningitis. Nat Rev Dis Primers. 2021;7:39.
4.Sáez-Llorens X, McCracken GH. Bacterial meningitis in children. Lancet. 2003;361(9375):2139–48.
5.Kim KS. Pathogenesis of bacterial meningitis: from bacteraemia to neuronal injury. Nat Rev Neurosci. 2020;21(2):87–103.
6.Oordt-Speets AM, Bolijn R, van Hoorn RC, Bhavsar A, Kyaw MH. Global etiology of bacterial meningitis. PLoS One. 2018;13(6):e0198772.
7.Tunkel AR, Hartman BJ, Kaplan SL, et al. Practice guidelines for bacterial meningitis. Clin Infect Dis. 2024;79(2):e1–e94.
8.Brouwer MC, McIntyre P, de Gans J, Prasad K, van de Beek D. Corticosteroids for acute bacterial meningitis. Cochrane Database Syst Rev. 2023;9:CD004405.
9.Principi N, Esposito S. Pediatric bacterial meningitis: current issues in pathogenesis and management. Infect Drug Resist. 2020;13:2197–2210.
10.Thigpen MC, Whitney CG, Messonnier NE, et al. Bacterial meningitis in the United States. N Engl J Med. 2011;364:2016–25.
11.McGill F, Heyderman RS, Michael BD, et al. Acute meningitis in adults and children: guidelines for diagnosis and management. J Infect. 2022;84(4):469–523.
12.Vázquez JA, Taha MK, Findlow J, et al. Global meningococcal disease epidemiology. Pediatr Infect Dis J. 2022;41(6):540–548.
13.Hasbun R, Bijlsma MW, Brouwer MC, et al. Risk score for identifying complications in bacterial meningitis. Clin Infect Dis. 2021;73(4):e707–e714.
14.Koedel U, Klein M, Pfister HW. New understandings on the pathophysiology of bacterial meningitis. Curr Opin Infect Dis. 2019;32(3):258–265.
15.World Health Organization. Meningitis fact sheet. Updated 2025.
16.American Academy of Pediatrics. Red Book: Report of the Committee on Infectious Diseases. 2025 Edition.
17.CDC. Meningococcal vaccination recommendations. Updated 2025.
18.CDC. Pneumococcal disease surveillance report. 2025.
19.WHO/UNICEF. Global immunization coverage report. 2025.
20.Swartz MN. Bacterial meningitis — a view of the past 90 years. N Engl J Med. 2004;351:1826–1828.




United Kingdom
Germany
France
Uzbekistan
Türkiye
Kazakhstan
Kyrgyzstan
Turkmenistan
Azerbaijan
India
Republic of Korea
Japan
United States of America
Kosovo
Italy
Spain
Poland
Netherlands
Belgium
Sweden
Norway
Finland
Denmark
Switzerland
Austria
Czech Republic
Hungary
Romania
Bulgaria
Greece
Portugal